Gerald L. Ray & Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $372K | Sell |
7,334
-1,720
| -19% | -$87.2K | 0.05% | 254 |
|
|
2017
Q2 | $488K | Hold |
9,054
| – | – | 0.06% | 222 |
|
|
2017
Q1 | $477K | Sell |
9,054
-4,000
| -31% | -$211K | 0.07% | 221 |
|
|
2016
Q4 | $628K | Sell |
13,054
-4,800
| -27% | -$231K | 0.09% | 194 |
|
|
2016
Q3 | $963K | Hold |
17,854
| – | – | 0.14% | 134 |
|
|
2016
Q2 | $967K | Hold |
17,854
| – | – | 0.15% | 125 |
|
|
2016
Q1 | $905K | Buy |
17,854
+116
| +0.7% | +$5.88K | 0.15% | 125 |
|
|
2015
Q4 | $895K | Sell |
17,738
-140
| -0.8% | -$7.06K | 0.14% | 127 |
|
|
2015
Q3 | $860K | Hold |
17,878
| – | – | 0.14% | 130 |
|
|
2015
Q2 | $931K | Sell |
17,878
-608
| -3% | -$31.7K | 0.14% | 138 |
|
|
2015
Q1 | $1.07M | Buy |
18,486
+1,880
| +11% | +$108K | 0.16% | 130 |
|
|
2014
Q4 | $887K | Buy |
16,606
+200
| +1% | +$10.7K | 0.14% | 135 |
|
|
2014
Q3 | $943K | Buy |
16,406
+2,200
| +15% | +$126K | 0.15% | 131 |
|
|
2014
Q2 | $950K | Hold |
14,206
| – | – | 0.16% | 128 |
|
|
2014
Q1 | $949K | Buy |
14,206
+448
| +3% | +$29.9K | 0.17% | 122 |
|
|
2013
Q4 | $918K | Hold |
13,758
| – | – | 0.17% | 119 |
|
|
2013
Q3 | $863K | Sell |
13,758
-800
| -5% | -$50.2K | 0.18% | 120 |
|
|
2013
Q2 | $910K | Buy |
+14,558
| New | +$910K | 0.2% | 108 |
|